A carregar...

The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing

In the European Union and Canada, an Ann Arbor strain live attenuated influenza vaccine (LAIV) is approved for use in children aged 2–17 years, including those with mild to moderate asthma or prior wheezing. The safety and efficacy of LAIV versus trivalent inactivated influenza vaccine (TIV) in chil...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ambrose, C. S., Dubovsky, F., Yi, T., Belshe, R. B., Ashkenazi, S.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3456911/
https://ncbi.nlm.nih.gov/pubmed/22410646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10096-012-1595-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!